187 related articles for article (PubMed ID: 35211427)
1. SLC39A1 Overexpression is Associated with Immune Infiltration in Hepatocellular Carcinoma and Promotes Its Malignant Progression.
Ma X; Zhuang H; Wang Q; Yang L; Xie Z; Zhang Z; Tan W; Tang C; Chen Y; Shang C
J Hepatocell Carcinoma; 2022; 9():83-98. PubMed ID: 35211427
[TBL] [Abstract][Full Text] [Related]
2. CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma.
Su J; Huang Y; Wang Y; Li R; Deng W; Zhang H; Xiong H
Cancer Cell Int; 2022 Feb; 22(1):67. PubMed ID: 35139863
[TBL] [Abstract][Full Text] [Related]
3. SLC39A1 contribute to malignant progression and have clinical prognostic impact in gliomas.
Wang P; Zhang J; He S; Xiao B; Peng X
Cancer Cell Int; 2020 Nov; 20(1):573. PubMed ID: 33292262
[TBL] [Abstract][Full Text] [Related]
4. Decreased SLC39A1 (Solute carrier family 39 member 1) expression predicts unfavorable prognosis in patients with early-stage hepatocellular carcinoma.
Zhang Q; Pan J; An F; Nie H; Zhan Q
Bioengineered; 2021 Dec; 12(1):8147-8156. PubMed ID: 34615436
[TBL] [Abstract][Full Text] [Related]
5. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
Zheng Y; Jiang L; Hu Y; Xiao C; Xu N; Zhou J; Zhou X
BMC Cancer; 2017 Feb; 17(1):161. PubMed ID: 28241806
[TBL] [Abstract][Full Text] [Related]
6.
Tong W; Yang L; Liu L; Liu X; Luo N
Onco Targets Ther; 2022; 15():555-570. PubMed ID: 35611367
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling.
Quan H; Li B; Yang J
Biomed Pharmacother; 2018 Nov; 107():754-762. PubMed ID: 30142536
[TBL] [Abstract][Full Text] [Related]
8. Upregulated Solute Carrier SLC39A1 Promotes Gastric Cancer Proliferation and Indicates Unfavorable Prognosis.
Yu D; Chen Y; Luo M; Peng Y; Yi S
Genet Res (Camb); 2022; 2022():1256021. PubMed ID: 36407082
[TBL] [Abstract][Full Text] [Related]
9. Identification of LSM Family Members as Novel Unfavorable Biomarkers in Hepatocellular Carcinoma.
Zhuang H; Chen B; Tang C; Chen X; Tan W; Yang L; Xie Z; Ma X; Wang Q; Zhang C; Shang C; Chen Y
Front Oncol; 2022; 12():871771. PubMed ID: 35646684
[TBL] [Abstract][Full Text] [Related]
10. DDX39 promotes hepatocellular carcinoma growth and metastasis through activating Wnt/β-catenin pathway.
Zhang T; Ma Z; Liu L; Sun J; Tang H; Zhang B; Zou Y; Li H
Cell Death Dis; 2018 Jun; 9(6):675. PubMed ID: 29867138
[TBL] [Abstract][Full Text] [Related]
11. NAP1L1 Functions as a Novel Prognostic Biomarker Associated With Macrophages and Promotes Tumor Progression by Influencing the Wnt/β-Catenin Pathway in Hepatocellular Carcinoma.
Shen B; Zhu W; Liu X; Jiang J
Front Genet; 2022; 13():876253. PubMed ID: 35664324
[TBL] [Abstract][Full Text] [Related]
12. FBXO17 promotes malignant progression of hepatocellular carcinoma by activating wnt/β-catenin pathway.
Liu FH; Cui YP; He YK; Shu RH
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8265-8273. PubMed ID: 31646557
[TBL] [Abstract][Full Text] [Related]
13. ASPM combined with KIF11 promotes the malignant progression of hepatocellular carcinoma via the Wnt/β-catenin signaling pathway.
Wu B; Hu C; Kong L
Exp Ther Med; 2021 Oct; 22(4):1154. PubMed ID: 34504599
[TBL] [Abstract][Full Text] [Related]
14. KIAA1522 Promotes the Progression of Hepatocellular Carcinoma via the Activation of the Wnt/β-Catenin Signaling Pathway.
Jiang S; Zhang Y; Li Q; Qiu L; Bian B
Onco Targets Ther; 2020; 13():5657-5668. PubMed ID: 32606779
[TBL] [Abstract][Full Text] [Related]
15. Bromodomain-containing protein 9 promotes hepatocellular carcinoma progression via activating the Wnt/β-catenin signaling pathway.
Fang D; Wang MR; Guan JL; Han YY; Sheng JQ; Tian DA; Li PY
Exp Cell Res; 2021 Sep; 406(2):112727. PubMed ID: 34370992
[TBL] [Abstract][Full Text] [Related]
16. Proline-rich protein 11 silencing inhibits hepatocellular carcinoma growth and epithelial-mesenchymal transition through β-catenin signaling.
Qiao W; Wang H; Zhang X; Luo K
Gene; 2019 Jan; 681():7-14. PubMed ID: 30248355
[TBL] [Abstract][Full Text] [Related]
17. ZMIZ2 facilitates hepatocellular carcinoma progression via LEF1 mediated activation of Wnt/β-catenin pathway.
Ding Y; Ning Y; Kang H; Yuan Y; Lin K; Wang C; Yi Y; He J; Li L; He X; Chang Y
Exp Hematol Oncol; 2024 Jan; 13(1):5. PubMed ID: 38254216
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA miR143HG predicts good prognosis and inhibits tumor multiplication and metastasis by suppressing mitogen-activated protein kinase and Wnt signaling pathways in hepatocellular carcinoma.
Lin X; Xiaoqin H; Jiayu C; Li F; Yue L; Ximing X
Hepatol Res; 2019 Aug; 49(8):902-918. PubMed ID: 30945380
[TBL] [Abstract][Full Text] [Related]
19. The Long Non-Coding RNA CASC2 Suppresses Cell Viability, Migration, and Invasion in Hepatocellular Carcinoma Cells by Directly Downregulating miR-183.
Sun J; Liu L; Zou H; Yu W
Yonsei Med J; 2019 Oct; 60(10):905-913. PubMed ID: 31538425
[TBL] [Abstract][Full Text] [Related]
20. TRIM66 confers tumorigenicity of hepatocellular carcinoma cells by regulating GSK-3β-dependent Wnt/β-catenin signaling.
Fan W; Du F; Liu X
Eur J Pharmacol; 2019 May; 850():109-117. PubMed ID: 30710548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
